121 related articles for article (PubMed ID: 2566883)
41. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
[TBL] [Abstract][Full Text] [Related]
42. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
43. Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta.
Arbogast LA; Voogt JL
Endocrinology; 1991 Feb; 128(2):997-1005. PubMed ID: 1703487
[TBL] [Abstract][Full Text] [Related]
44. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.
Zhou FC; Bledsoe S; Murphy J
Brain Res; 1991 Aug; 556(1):108-16. PubMed ID: 1718555
[TBL] [Abstract][Full Text] [Related]
45. Combined in situ hybridization and immunocytochemistry in the assay of pharmacological effects on tyrosine hydroxylase mRNA concentration.
Pasinetti GM; Morgan DG; Johnson SA; Lerner SP; Myers MA; Poirier J; Finch CE
Pharmacol Res; 1989; 21(3):299-311. PubMed ID: 2568627
[TBL] [Abstract][Full Text] [Related]
46. Characterization of fetal antigen 1/delta-like 1 homologue expressing cells in the rat nigrostriatal system: effects of a unilateral 6-hydroxydopamine lesion.
Liechti R; Ducray AD; Jensen P; Di Santo S; Seiler S; Jensen CH; Meyer M; Widmer HR
PLoS One; 2015; 10(2):e0116088. PubMed ID: 25723595
[TBL] [Abstract][Full Text] [Related]
47. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
48. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
[TBL] [Abstract][Full Text] [Related]
49. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.
Dravid A; Jaton AL; Enz A; Frei P
Brain Res; 1984 Oct; 311(2):361-5. PubMed ID: 6149789
[TBL] [Abstract][Full Text] [Related]
50. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta.
Sanderson P; Mavoungou R; Albe-Fessard D
Neurosci Lett; 1986 Jun; 67(1):25-30. PubMed ID: 3014391
[TBL] [Abstract][Full Text] [Related]
51. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
52. 6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase.
Kunikowska G; Jenner P
Brain Res; 2001 Dec; 922(1):51-64. PubMed ID: 11730701
[TBL] [Abstract][Full Text] [Related]
53. Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats.
Dickerson JW; Hemmerle AM; Numan S; Lundgren KH; Seroogy KB
Neuroscience; 2009 Sep; 163(1):482-9. PubMed ID: 19505538
[TBL] [Abstract][Full Text] [Related]
54. Osteopontin expression in activated glial cells following mechanical- or toxin-induced nigral dopaminergic cell loss.
Iczkiewicz J; Rose S; Jenner P
Exp Neurol; 2007 Sep; 207(1):95-106. PubMed ID: 17643430
[TBL] [Abstract][Full Text] [Related]
55. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
Glavan G; Zivin M
Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
[TBL] [Abstract][Full Text] [Related]
56. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
57. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine.
Rodríguez-Gómez JA; Romero-Ramos M; Vizuete ML; Venero JL; Cano J; Machado A
Mol Pharmacol; 1997 Oct; 52(4):641-7. PubMed ID: 9380027
[TBL] [Abstract][Full Text] [Related]
58. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
59. 6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra.
Venero JL; Beck KD; Hefti F
Neuroreport; 1994 Jan; 5(4):429-32. PubMed ID: 8003668
[TBL] [Abstract][Full Text] [Related]
60. A unilateral 6-hydroxydopamine lesion decreases the expression of metabotropic glutamate receptors in rat substantia nigra.
Gu B; Zhang YD; Hu G
Neurosci Lett; 2003 Nov; 351(3):186-90. PubMed ID: 14623137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
